Skip to main content
. Author manuscript; available in PMC: 2019 Sep 15.
Published in final edited form as: J Immunol. 2018 Aug 6;201(6):1662–1670. doi: 10.4049/jimmunol.1800267

Table 1.

Demographic data of patients analyzed by libraries

N 29
Age (years) 24.9±2.88 (SEM), range 14–63
Gender (M/F) 11/18
Disease duration (years) 16.7±2.52 (SEM), range 0–50 yrs
GADA positive 75%
IA-2A positive 58%
ZnT8 positive 42%
*

includes samples and data from 3 concordant triplets and 2 concordant twins ages 63 and 32 yrs.